| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 2160* | 2021 |
| Antibody status and incidence of SARS-CoV-2 infection in health care workers SF Lumley, D O’Donnell, NE Stoesser, PC Matthews, A Howarth, ... New England Journal of Medicine 384 (6), 533-540, 2021 | 1057 | 2021 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 803 | 2021 |
| Screening out irrelevant cell-based models of disease P Horvath, N Aulner, M Bickle, AM Davies, ED Nery, D Ebner, ... Nature reviews Drug discovery 15 (11), 751-769, 2016 | 548 | 2016 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 464* | 2021 |
| Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ... The Lancet Respiratory Medicine 10 (8), 761-775, 2022 | 345 | 2022 |
| Pregnancy and neonatal outcomes of COVID‐19: coreporting of common outcomes from PAN‐COVID and AAP‐SONPM registries E Mullins, ML Hudak, J Banerjee, T Getzlaff, J Townson, K Barnette, ... Ultrasound in Obstetrics & Gynecology 57 (4), 573-581, 2021 | 326 | 2021 |
| Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison M Ainsworth, M Andersson, K Auckland, JK Baillie, E Barnes, S Beer, ... The Lancet Infectious Diseases 20 (12), 1390-1400, 2020 | 320 | 2020 |
| The duration, dynamics and determinants of SARS-CoV-2 antibody responses in individual healthcare workers SF Lumley, J Wei, D O’Donnell, NE Stoesser, PC Matthews, A Howarth, ... MedRxiv, 2020.11. 02.20224824, 2020 | 307* | 2020 |
| Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study DW Eyre, SF Lumley, D O'Donnell, M Campbell, E Sims, E Lawson, ... elife 9, e60675, 2020 | 283 | 2020 |
| TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions T Leng, HD Akther, CP Hackstein, K Powell, T King, M Friedrich, ... Cell reports 28 (12), 3077-3091. e5, 2019 | 235 | 2019 |
| Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 200 | 2021 |
| Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey KB Pouwels, T House, E Pritchard, JV Robotham, PJ Birrell, A Gelman, ... The Lancet Public Health 6 (1), e30-e38, 2021 | 198 | 2021 |
| Defining the functional role of NaV1. 7 in human nociception LA McDermott, GA Weir, AC Themistocleous, AR Segerdahl, I Blesneac, ... Neuron 101 (5), 905-919. e8, 2019 | 188 | 2019 |
| The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer LL da Motta, I Ledaki, K Purshouse, S Haider, MA De Bastiani, D Baban, ... Oncogene 36 (1), 122-132, 2017 | 167 | 2017 |
| Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status DW Eyre, SF Lumley, J Wei, S Cox, T James, A Justice, G Jesuthasan, ... Clinical Microbiology and Infection 27 (10), 1516. e7-1516. e14, 2021 | 150 | 2021 |
| An observational cohort study on the incidence of SARS-CoV-2 infection and B. 1.1. 7 variant infection in healthcare workers by antibody and vaccination status SF Lumley, G Rodger, B Constantinides, N Sanderson, KK Chau, ... MedRxiv, 2021.03. 09.21253218, 2021 | 99* | 2021 |
| Systematic functional characterization of candidate causal genes for type 2 diabetes risk variants SK Thomsen, A Ceroni, M van de Bunt, C Burrows, A Barrett, ... Diabetes 65 (12), 3805-3811, 2016 | 96 | 2016 |
| Oxford University Hospitals Staff Testing Group SF Lumley, D O’Donnell, NE Stoesser, PC Matthews, A Howarth, ... Antibody status and incidence of SARS-CoV-2 infection in health care workers …, 2021 | 87 | 2021 |
| The kinase chemogenomic set (KCGS): an open science resource for kinase vulnerability identification CI Wells, H Al-Ali, DM Andrews, CRM Asquith, AD Axtman, I Dikic, ... International journal of molecular sciences 22 (2), 566, 2021 | 85 | 2021 |
